Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124198) titled 'An Exploratory Study of Azvudine in HIV/AIDS Patients with Incomplete Immune Reconstitution' on May 8.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Pingmei Shenma Medical Group General Hospital
Condition:
HIV/AIDS patients with incomplete immune reconstitution
Intervention:
Test group:FNC+TDF+3TC+EFV, or FNC+TDF+3TC+LPV/r, or FNC+TDF+3TC+NVP, or FNC+AZT+3TC+EFV, or FNC+AZT+3TC+LPV/r, or FNC+AZT+3TC+NVP, or FNC+3TC+DTG
(Azvudine,FNC
Tenofovir Disoproxil Fumarate,TDF
Efavirenz,EFV
Lopinavir/ritonavir, LPV/r
nevirapine,NVP
zidovudine,AZT
lamividine,3TC
Recruitment Status: Not Rec...